What Do We Know about the Serotonergic Genetic Heterogeneity in Attention-Deficit/Hyperactivity and Autistic Disorders?
The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Shared candidate gene regions point to a link between autistic disorders and attention-deficit/hyperactivity disorder (ADHD). Although they represent nosologically different diagnoses, the disorders do show some shared symptoms, above all inattention. For both disorders, the association with the serotonergic system is a focus of current research. SAMPLING AND METHODS: The current work provides an overview of serotonergic mechanisms in ADHD and autistic disorders as well as the resulting pharmacogenetic approaches. RESULTS: No uniform picture emerges either for ADHD or for autistic disorders. In pharmacogenetic terms, there are some isolated studies on associations between serotonergic mechanisms and pharmacotherapy. For the area of autism, such studies are still lacking. CONCLUSIONS: The presented serotonergic mechanisms show relationships of this polymorphism to ADHD and autistic disorders, but they do not result in a uniform picture. The overlaps can best be explained by a dimensional classification approach. As yet, only a small number of studies on attentional disorders in autism and ADHD using shared samples have been carried out. With regard to diagnostics and therapy, analyses on the etiology of the attentional disorder of ADHD and autism are required.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interest in the co-occurrence of ADHD and ASD has grown tremendously in the last decade, with multiple published studies addressing questions of heritability and shared etiology [13,15,124], as well as common phenotypic and endophenotypic features [17,42].”
From Treatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder (2012) · cites this paper as [124]
Citations
Cites
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162 · cited 1×
“In an experiment on anxiety disorders, in 1996, Lesch et al. [”
MethodHyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476 · cited 1×
“For instance, knock-out mice without a gene for the encoding of the plasma membrane dopamine transporter (DAT) show hyperactivity, which has proved to be consistent with an increased extracellular dopamine concentration [”
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221 · cited 1×
“described for the first time a new type of 44-bp insertion/deletion in the promotor region of the serotonin transporter, which is represented in long (L) and short (S) alleles. The S form leads to a limited transcription and a reduced amount of the transporter. The L form is associated with a quicker uptake of 5-HTT p…”
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.564 · Cited by 1,738
Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity
Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885
Greenberg, B. D., Tolliver, T. J., Huang, S.-J., Li, Q., Bengel, D., & Murphy, D. L. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990205)88:1<83::aid-ajmg15>3.0.co;2-0 · Cited by 533 · cited 1×
“The L/L and the L/S variants show, in comparison to the S form, higher amounts on 5-HTT platelets [”
Kelsey, D. K., Sumner, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., Sutton, V. K., Gonzales, J., Malcolm, S. K., Schuh, K. J., et al. (2004) · Pediatrics · doi:10.1542/peds.114.1.e1 · Cited by 464 · cited 1×
“It is still not clear whether or not there is a real effect on ADHD psychopathology. Noradrenergic substances (atomoxetine) have also proved to be effective in the treatment of ADHD [”
Serotonin Transporter: Gene, Genetic Disorders, and Pharmacogenetics
Murphy, D. L. (2004) · Molecular Interventions · doi:10.1124/mi.4.2.8 · Cited by 448 · cited 1×
“or by other authors also as ‘serotonin transporter promoter region’ (5-HTTLPR) [”
Evidence of linkage between the serotonin transporter and autistic disorder
Jr, E. C., Courchesne, R., Lord, C., Cox, N. J., Yan, S., Lincoln, A., Haas, R., Courchesne, E., & Leventhal, B. L. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000266 · Cited by 425
Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman, S., & Iyengar, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300627 · Cited by 408
Research works printed but not linked: 2
- 10.1097%2F00041444-200306000-00009 · doi:10.1097/00041444-200306000-00009
- 10.1097%2F00004583-199109000-00010 · DOI
Cited by
Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder
Rommelse, N. N. J., Franke, B., Geurts, H. M., Hartman, C. A., & Buitelaar, J. K. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0092-x · Cited by 564
“Accordingly, genes related to these pathways have been the prime candidates for molecular investigation in both disorders [5, 87; see also elsewhere in this issue].”
InfluentialTreatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder
Davis, N. O., & Kollins, S. H. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0126-9 · Cited by 156
The comorbidity of ADHD and autism spectrum disorder
Antshel, K. M., Zhang-James, Y., & Faraone, S. V. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.840417 · Cited by 147
Chantiluke, K., Barrett, N., Giampietro, V., Santosh, P., Brammer, M., Simmons, A., Murphy, D. G., & Rubia, K. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3837-2 · Cited by 63
“Thus, polymorphisms of serotonergic genes have been associated with both ADHD and ASD (Rommelse et al. 2010; Sinzig and Lehmkuhl 2007).”
BackgroundChantiluke, K., Barrett, N., Giampietro, V., Brammer, M., Simmons, A., Murphy, D. G., & Rubia, K. (2015) · Cerebral Cortex · doi:10.1093/cercor/bht365 · Cited by 59
Metadata
- Authors
- Sinzig, J., & Lehmkuhl, G.
- Affiliations
- University of Cologne (DE)
- ORCID
- Sinzig, J.
- Venue
- Psychopathology
- Publisher
- S. Karger AG
- Published
- 2007
- Volume
- 40
- Issue
- 5
- Pages
- 329-337
- ISSN
- 0254-4962 (ISSN-L)
- 1423-033X
- OpenAlex
- W2026949173
- Cited by
- 14
- References
- 91
- Citations by year
- 2018: 1 · 2017: 1 · 2015: 1 · 2014: 2 · 2013: 2 · 2012: 3
- FWCI
- 0.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychopathology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- attention deficit hyperactivity disorder, autism spectrum disorder, serotonergic system, genetic polymorphism, pharmacogenetics, inattention, dimensional classification
- MeSH terms
- Attention Deficit Disorder with Hyperactivity, Autistic Disorder, Child, Chromosomes, Human, Pair 17, Genotype, Humans, Promoter Regions, Genetic, Comorbidity, Selective Serotonin Reuptake Inhibitors, Minisatellite Repeats, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: What Do We Know about the Serotonergic Genetic Heterogeneity in Attention-Deficit/Hyperactivity and Autistic Disorders? https://app.cochat.ai/papers/10.1159/000105531
- The paper
- Sinzig, J., & Lehmkuhl, G. (2007). What Do We Know about the Serotonergic Genetic Heterogeneity in Attention-Deficit/Hyperactivity and Autistic Disorders? Psychopathology. https://doi.org/10.1159/000105531
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.